Gunderson Dettmer Stough Villeneuve Franklin & Hachigian acted as counsel to Flywire, and Goodwin Procter acted as counsel to the underwriters. Flywire Corporation (Nasdaq: FLYW) announced its underwritten...
You must be a Standard 1 Year member to access this content.
Weil, Gotshal & Manges LLP represented AltC Acquisition Corp., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Oklo Inc. in the transaction. An advanced...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...
You must be a Standard 1 Year member to access this content.
Davis Polk advised GSK plc on the deal while Gunderson Dettmer represented Affinivax. GSK plc announced its acquisition of Affinivax, Inc. for a $2.1 billion upfront...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Synchronoss on the deal. Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP advised Flywire on the deal. Boston-based global payments enablement and software company, Flywire, announced its initial public offering. The company...
You must be a Standard 1 Year member to access this content.
